Cancer clinical trials in Australia

Using registry data to identify gaps in research and enhance our clinical trial activity

Correspondence: ian.olver@cancer.org.au

1. Dear RF, Barratt AL, McGeechan K, et al. Landscape of cancer clinical trials in Australia: using trial registries to guide future research. Med J Aust 2011; 194: 387-391. <MJA full text>
2. MacKenzie R, Chapman S, Johnson N, et al. The newsworthiness of cancer in Australian television news. Med J Aust 2008; 189: 155-158. <MJA full text>
3. Pharmaceuticals Industry Strategy Group. Final report December 2008. Canberra: Commonwealth of Australia, 2009.
4. Medicines Australia. How to save Australia’s declining clinical trials [media release]. 18 Feb 2011. http://medicinesaustralia.com.au/2011/02/18/how-to-save-australias-declining-clinical-trials (accessed Mar 2011).
5. Access Economics. Exceptional returns: the value of investing in health R&D in Australia II. Report prepared for Australian Society for Medical Research. Canberra: Access Economics, 2008.
6. Stead M, Cameron D, Lester N, et al. Strengthening clinical cancer research in the United Kingdom. Br J Cancer 2011; Mar 1. [Epub ahead of print.]
7. Béhier JM, Reynier JC, Bertoye PH, Vray M; participants of Round Table no2 of Giens XXV. Clinical trials and E-health: impact of new information technology applied to clinical trials (including source data-medical records) and to human and drug research. Therapie 2010; 65: 317-322.
8. Boult M, Fitzpatrick K, Maddern G, Fitridge R. A guide to multi-centre ethics for surgical research in Australia and New Zealand. ANZ J Surg 2011; 81: 132-136.

Online responses are no longer available. Please refer to our instructions for authors page for more information.